eli lilly news glp-1 Retatrutide, the next generation of drug from Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced. In Eli Lilly stock soars on

6.2 Modulation of gut microbiota Recent research suggests that GLP-1 receptor agonists significantly affect the composition of gut microbiota, revealing a new mechanism that contributes to metabolic advantages (Liang et al

Pamela Abdy and Michael De Luca Title: Co-Chair and CEO, Warner Bros

Safety Considerations and Who Should Proceed Cautiously Patients with active IBS-C, history of severe constipation, or bowel obstruction should approach GLP-1 therapy with particular caution

Cannabis may counteract Ozempic's appetite-suppressing effects and cause unpredictable fluctuations in blood glucose levels

DW: I believe that IV vitamin therapy is a valuable treatment option when provided by a medical professional, and that it works for many patients